Our meta-analysis showed that the GSTM1 null genotype was associated with a statistically elevated risk of CHD (OR = 1.38, 95% CI: 1.15, 1.65), which was consistent with the study by Wang et al. [51], but not the study by Zhou et al. [52]. Here, GSTM1 is linked to coronary artery disorder.